Download PDF
Thromb Haemost 2001; 86(05): 1176-1180
DOI: 10.1055/s-0037-1616047
Review Article
Schattauer GmbH

Myocardial Troponin T Release Is Associated with Enhanced Fibrinolysis in Patients with Acute Coronary Syndromes

Raila Ehlers
1   Medizinische Klinik, Abteilung III, Eberhard-Karls-Universität Tübingen, Germany
,
Eva Büttcher
1   Medizinische Klinik, Abteilung III, Eberhard-Karls-Universität Tübingen, Germany
,
Silke Kazmaier
1   Medizinische Klinik, Abteilung III, Eberhard-Karls-Universität Tübingen, Germany
,
Martin E. Beyer
1   Medizinische Klinik, Abteilung III, Eberhard-Karls-Universität Tübingen, Germany
,
Uwe Helber
1   Medizinische Klinik, Abteilung III, Eberhard-Karls-Universität Tübingen, Germany
,
Sebastian Szabo
1   Medizinische Klinik, Abteilung III, Eberhard-Karls-Universität Tübingen, Germany
,
Hans Peter Wendel
1   Medizinische Klinik, Abteilung III, Eberhard-Karls-Universität Tübingen, Germany
,
Hans Martin Hoffmeister
1   Medizinische Klinik, Abteilung III, Eberhard-Karls-Universität Tübingen, Germany
› Author Affiliations
Further Information

Publication History

Received 15 December 2000

Accepted after resubmission 20 July 2001

Publication Date:
13 December 2017 (online)

Also available at
    Permissions and Reprints

Summary

Patients with acute coronary syndromes (ACS) frequently present with signs of disturbed fibrinolysis. The present study investigates the correlation of alterations in the fibrinolytic system and the amount of myocardial damage characterized by troponin release.

In 85 patients with ACS markers of plasmin activation, plasminogen activator system and troponin T (TnT) were measured initially and after 48 h. Patients with TnT release (≥ 0.01 g/l) at admission had higher TPA levels than those without release (10.2 ± 0.7 ng/ml vs. 7.6 ± 0.5 ng/ml; p <0.01). Additionally, patients with positive TnT had higher D-dimer levels initially (457 ± 39 ng/ml vs. 316 ± 22 ng/ml; p < 0.01) and 48 h later (451 ± 42 ng/ml vs. 275 ± 37 ng/ml; p < 0.01). The association of myocardial damage with a prothrombotic state and an enhanced fibrinolysis may explain the high prognostic value of troponin measurements in respect to future coronary events.

Keywords

Acute coronary syndromes - fibrinolytic system - plasminogen activator system - plasmin activation - troponin T
 

  • References

  • 1 Hoffmeister HM, Jur M, Wendel HP, Heller W, Seipel L. Alterations of the coagulation, the fibrinolytic and the kallikrein-kinin system in the acute and post-acute phase in patients with unstable angina pectoris. Circulation 1995; 91: 2520-7.
    CrossrefPubMedGoogle Scholar
  • 2 Munkvad S. Fibrinolysis in patients with acute ischemic heart disease. Danish Medical Bulletin 1993; 40: 383-408.
    PubMedGoogle Scholar
  • 3 Panchenko E, Dobrovolsky A, Davletov K, Titaeva E, Kravets A, Podinovskaya J, Karpov Y. D-dimer and fibrinolysis in patients with various degrees of atherosclerosis. Eur Heart J 1995; 16: 38-42.
    PubMedGoogle Scholar
  • 4 Loskutoff DJ, van Aken BE, Seiffert D. Abnormalities in the fibrinolytic system of the vascular wall associated with atherosclerosis. Annals of the New York Academy of Science 1995; 748: 177-84.
    PubMedGoogle Scholar
  • 5 ECAT Angina pectoris study group.. ECAT Angina pectoris study: baseline associations of haemostatic factor with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J 1993; 14: 8-17.
    PubMedGoogle Scholar
  • 6 Munkvad S, Gram J, Jespersen J. A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction. Eur Heart J 1990; 11: 525-8.
    CrossrefPubMedGoogle Scholar
  • 7 Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-8.
    CrossrefPubMedGoogle Scholar
  • 8 Kruskal JB, Commerford PJ, Franks JJ, Kirsch RE. Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. J Med 1987; 317: 1361-5.
    PubMedGoogle Scholar
  • 9 Bayes-Genis A, Mateo J, Santalo M, Oliver A, Guindo J, Badimon L, Martinez-Rubio A, Fontcuberta J, Schwartz RS, Bayes de Luna A. D-dimer is an early diagnostic marker of coronary ischemia in patients with chest pain. Am Heart J 2000; 140: 379-84.
    CrossrefPubMedGoogle Scholar
  • 10 Hoffmeister HM, Szabo S, Kastner C, Beyer ME, Helber U, Kazmaier S, Wendel HP, Heller W, Seipel L. Thrombolytic therapy in acute myocardial infarction. Circulation 1998; 98: 2527-33.
    CrossrefPubMedGoogle Scholar
  • 11 Terres W, Kümmel P, Sudrow A, Reuter H, Meinertz T, Hamm CW. Enhanced coagulation activation in troponin T-positive unstable angina pectoris. Am Heart J 1998; 135: 281-6.
    CrossrefPubMedGoogle Scholar
  • 12 Ohman E, Armstrong P, Christenson R. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996; 335: 1333-41.
    CrossrefPubMedGoogle Scholar
  • 13 Gotoh K, Minamino T, Katoh, Hamano Y Fukui S, Hori M, Kusuoka H, Mishima M, Inoue M, Kamada T. The role of intracoronary thrombus in unstable angina pectoris: angiographic assessment and thrombolytic therapy during ongoing anginal attacks. Circulation 1988; 77: 526-34.
    CrossrefPubMedGoogle Scholar
  • 14 Zalewski A, Shi Y, Nardone D, Bravette B, Weinstock P, Fischman D, Wilson P, Goldberg S, Levin DC, Bjornsson TD. Evidence for reduced fibrinolytic activity in unstable angina at rest. Circulation 1991; 83: 1685-91.
    CrossrefPubMedGoogle Scholar
  • 15 Hamm CW, Heeschen C, Goldmann B, Vahanian A, Adgey J, Miguel CM, Rutsch W, Berger J, Kootstra J, Simoons ML. Benefit of Abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med 1999; 340: 1623-9.
    CrossrefPubMedGoogle Scholar
  • 16 Braunwald E. Unstable angina: a classification. Circulation 1989; 80: 410-4.
    CrossrefPubMedGoogle Scholar
  • 17 Katus HA, Loser S, Hallermayer K, Remppis A, Scheffold T, Borgyaa A, Essig U, Geuss U. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem 1992; 38: 386-93.
    CrossrefPubMedGoogle Scholar
  • 18 Noda-Heiny H, Daugherty A, Sobel BE. Augmented urokinase receptor expression in atheroma. Arterios Thromb Vasc Biol 1995; 15: 37-43.
    PubMedGoogle Scholar
  • 19 Hoffmeister HM, Jur M, Ruf-Lehmann M, Helber U, Heller W, Seipel L. Endothelial tissue-type plasminogen activator release in coronary heart disease. JACC 1998; 31: 547-51.
    CrossrefPubMedGoogle Scholar
  • 20 Francis RB, Kawanishi D, Baruch T, Mahrer P, Rahimtoola S, Feinstein DI. Impaired fibrinolysis in coronary artery disease. Am Heart J 1988; 115: 776-80.
    CrossrefPubMedGoogle Scholar
  • 21 Hoffmeister HM, Jur M, Helber U, Fischer M, Heller W, Seipel L. Correlation between coronary morphology and molecular markers of fibrinolysis in unstable angina pectoris. Atherosclerosis 1999; 144: 151-7.
    PubMedGoogle Scholar
  • 22 Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. JACC 1998; 31: 1460-5.
    CrossrefPubMedGoogle Scholar
  • 23 Padro T, Emeis JJ, Steins M, Schmid KW, Kienast J. Quantification of plasminogen activators and their inhibitors in the aortic vessel in relation to the presence and severity of atherosclerotic disease. Arterioscler Thromb Vasc Biol 1985; 15: 893-902.
    PubMedGoogle Scholar
  • 24 Kapiotis S, Jilma B, Quehenberger P, Ruzicka K, Handler S, Speiser W. Morning Hypercoagulability and Hypofibrinolysis. Circulation 1997; 96: 19-21.
    CrossrefPubMedGoogle Scholar
  • 25 Blasi F. Fibrinolytic tests and extravascular proteolysis: urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Fibrinolysis 1993; 7: 17-8.
    PubMedGoogle Scholar
  • 26 Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Dano K. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J 1990; 9: 467-74.
    PubMedGoogle Scholar
  • 27 Cubellis MV, Wun T-C, Blasi F. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J 1990; 9: 1079-85.
    PubMedGoogle Scholar
  • 28 Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368: 419-24.
    CrossrefPubMedGoogle Scholar